Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $4.61 $6.39 Thursday, 9th May 2024 AFMD stock ended at $5.24. This is 0.0956% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.82% from a day low at $5.14 to a day high of $5.28.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
Jul 06, 2016 $27.10 $27.10 $27.10 $27.10 11 460
Jul 05, 2016 $26.70 $26.70 $26.70 $26.70 12 590
Jul 01, 2016 $27.80 $27.80 $27.80 $27.80 15 620
Jun 30, 2016 $24.80 $24.80 $24.80 $24.80 39 230
Jun 29, 2016 $23.90 $23.90 $23.90 $23.90 82 350
Jun 28, 2016 $25.20 $25.20 $25.20 $25.20 45 620
Jun 27, 2016 $25.40 $25.40 $25.40 $25.40 40 370
Jun 24, 2016 $29.40 $29.40 $29.40 $29.40 162 520
Jun 23, 2016 $32.70 $32.70 $32.70 $32.70 27 610
Jun 22, 2016 $30.20 $30.20 $30.20 $30.20 20 710
Jun 21, 2016 $29.40 $29.40 $29.40 $29.40 24 400
Jun 20, 2016 $30.50 $30.50 $30.50 $30.50 14 290
Jun 17, 2016 $30.30 $30.30 $30.30 $30.30 30 640
Jun 16, 2016 $32.60 $32.60 $32.60 $32.60 14 914
Jun 15, 2016 $32.10 $32.10 $32.10 $32.10 18 691
Jun 14, 2016 $30.60 $30.60 $30.60 $30.60 23 883
Jun 13, 2016 $31.90 $31.90 $31.90 $31.90 18 279
Jun 10, 2016 $31.50 $31.50 $31.50 $31.50 22 855
Jun 09, 2016 $34.10 $34.10 $34.10 $34.10 15 632
Jun 08, 2016 $37.50 $37.50 $37.50 $37.50 6 563
Jun 07, 2016 $36.90 $36.90 $36.90 $36.90 8 046
Jun 06, 2016 $37.40 $37.40 $37.40 $37.40 16 174
Jun 03, 2016 $36.20 $36.20 $36.20 $36.20 11 074
Jun 02, 2016 $36.90 $36.90 $36.90 $36.90 11 158
Jun 01, 2016 $35.00 $35.00 $35.00 $35.00 9 255
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT